Emerging Risk Factors for Urologic Diseases

Xiangyi Lu
{"title":"Emerging Risk Factors for Urologic Diseases","authors":"Xiangyi Lu","doi":"10.1177/117956110800200001","DOIUrl":null,"url":null,"abstract":"Modern medicine has brought us many miracle cures. In the 21st century, especially, we are blessed with increasingly powerful disease combating tools, such as functional genomics, proteomics and stem cells. Decades of medical and pharmaceutical research have produced thousands of medicines that allow us to treat and prevent diseases better than ever before. Furthermore, risk factors for many major diseases are being identified. To name a few, we now know that high cholesterol and chronic inflammation are two most prominent risk factors for cardiovascular diseases. We also know that obesity is one of the major contributing factors for type II diabetes. Cigarette smoking and air pollution are major environmental causes of respiratory diseases and lung cancers. Unfortunately, specific risk factors for many urologic diseases are yet to be identified. In this editorial, I will discuss emerging urologic risk factors based on recent research findings and their implications on what we should be looking ahead. Understanding risk factors is obviously important because it allows us to avoid disease development in the first place. Risk assessment facilitates clinical prognosis and understanding of disease development mechanisms.","PeriodicalId":89908,"journal":{"name":"Clinical medicine insights. Urology","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical medicine insights. Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/117956110800200001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Modern medicine has brought us many miracle cures. In the 21st century, especially, we are blessed with increasingly powerful disease combating tools, such as functional genomics, proteomics and stem cells. Decades of medical and pharmaceutical research have produced thousands of medicines that allow us to treat and prevent diseases better than ever before. Furthermore, risk factors for many major diseases are being identified. To name a few, we now know that high cholesterol and chronic inflammation are two most prominent risk factors for cardiovascular diseases. We also know that obesity is one of the major contributing factors for type II diabetes. Cigarette smoking and air pollution are major environmental causes of respiratory diseases and lung cancers. Unfortunately, specific risk factors for many urologic diseases are yet to be identified. In this editorial, I will discuss emerging urologic risk factors based on recent research findings and their implications on what we should be looking ahead. Understanding risk factors is obviously important because it allows us to avoid disease development in the first place. Risk assessment facilitates clinical prognosis and understanding of disease development mechanisms.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
泌尿系统疾病新出现的危险因素
现代医学给我们带来了许多神奇的治疗方法。特别是在21世纪,我们有幸拥有越来越强大的疾病防治工具,如功能基因组学、蛋白质组学和干细胞。几十年的医学和制药研究已经产生了数千种药物,使我们能够比以往任何时候都更好地治疗和预防疾病。此外,正在确定许多重大疾病的危险因素。举几个例子,我们现在知道高胆固醇和慢性炎症是心血管疾病的两个最突出的危险因素。我们也知道肥胖是导致二型糖尿病的主要因素之一。吸烟和空气污染是导致呼吸系统疾病和肺癌的主要环境因素。不幸的是,许多泌尿系统疾病的具体危险因素尚未确定。在这篇社论中,我将根据最近的研究结果讨论新出现的泌尿系统危险因素及其对我们应该展望的影响。了解风险因素显然很重要,因为它可以让我们首先避免疾病的发展。风险评估有助于临床预后和了解疾病发展机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Prevalence and Forecast Prevalence of Overactive Bladder in the Medicare Population Clinical Outcomes of Retrograde Intrarenal Surgery as a Primary Treatment for Staghorn Calculi: A Single-Center Experience Urinary pH as a Target in the Management of Lithiasic Patients in Real-World Practice: Monitoring and Nutraceutical Intervention for a Nonlithogenic pH Range Role of Serum and Urinary Biomarkers in Evaluation and Management of Patients With Overactive Bladder Treatment of Metastatic Renal Cell Carcinoma: Latest Evidence and Ongoing Challenges
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1